US.IDXX · Idexx Laboratories

{
  "risk": {
    "level": "Medium",
    "reason": "risk management score >= 6.5/10",
    "position": {
      "score": 1.4,
      "details": {
        "atrPct": 2.6800276861496397,
        "turnoverUsdM": 202.69913211623,
        "liquidityPoints": 0.4,
        "volatilityPoints": 1
      }
    },
    "rrPoints": 1.4,
    "stopLevels": {
      "symbol": "US.IDXX",
      "rr_range": "1:1.0-1:2.5",
      "risk_profile": "中等",
      "stop_loss_price": 477.6478,
      "strength_details": {
        "ma_score": 1,
        "atr_score": 2,
        "rsi_score": 2.5,
        "macd_score": 1,
        "volume_score": 1
      },
      "market_adjustment": 1,
      "risk_reward_ratio": 1,
      "stop_loss_percent": 5.4,
      "take_profit_price": 529.935,
      "target_multiplier": 1.6,
      "technical_strength": 1.45,
      "take_profit_percent": 5
    },
    "positionPoints": 1.4,
    "stopLossPoints": 1.8,
    "diversification": {
      "score": 2,
      "details": {
        "method": "sector concentration proxy; no portfolio holdings used",
        "sector": "Health Care",
        "concentratedSectorPenalty": 0
      }
    },
    "riskRewardRatio": 1.2,
    "stopLossPercent": 5.360055372299279,
    "diversificationPoints": 2
  },
  "total": {
    "max": 160,
    "result": 43.6,
    "formula": "score_with_momentum_v2 = main_score + momentum_5d_v2_score",
    "baseScore": 42.6,
    "modelVersion": "cursor_18_27_news_v2_160",
    "momentum5dScore": 1
  },
  "market": {
    "ma20": 541.5245,
    "ma50": 556.0482,
    "close": 504.7,
    "prevClose": 506.53,
    "avgVolume20": 499946,
    "volumeRatio": 0.8,
    "changePercent": -0.36
  },
  "sources": {
    "catalyst": "finnhub_news_keyword_model",
    "sentiment": "finnhub_news_keyword_model",
    "fundamentals": "fmp_stable",
    "institutional": null,
    "marketContext": "twelvedata+fred"
  },
  "barCount": 60,
  "momentum": {
    "max": 50,
    "result": 1,
    "details": {
      "ret_5d": -0.046458408300115495,
      "max_score": 50,
      "max_total": 50,
      "raw_total": 1,
      "vcp_bonus": 0,
      "vol_ratio": 0.7945928834986992,
      "ret_points": 0,
      "vol_points": 0,
      "range_ratio": 0.7687946539667995,
      "volat_points": 0,
      "day_range_pct": 0.020398275799518986,
      "model_version": "cursor_18_27_news_v2_160",
      "available_bars": 30,
      "breakout_points": 0,
      "partial_history": false,
      "pullback_points": 1,
      "breakout_vol_bonus": 0,
      "first_breakout_20d": false,
      "return_window_days": 5,
      "first_breakout_bonus": 0,
      "breakout_quality_points": 0
    },
    "formula": "Cursor_18.25 5D momentum v2 0-50",
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "scoreMax": 110,
  "composite": {
    "max": 160,
    "result": 43.6,
    "formula": "Cursor_18.25 ranking score v2 (score_with_momentum_v2)",
    "weights": [
      {
        "raw": 4.5,
        "label": "基本面",
        "weight": "5/110",
        "normalized": 90,
        "contribution": 4.5
      },
      {
        "raw": 5.2,
        "label": "資金流",
        "weight": "20/110",
        "normalized": 26,
        "contribution": 5.2
      },
      {
        "raw": 6.6,
        "label": "市場環境",
        "weight": "15/110",
        "normalized": 44,
        "contribution": 6.6
      },
      {
        "raw": 2,
        "label": "催化劑",
        "weight": "20/110",
        "normalized": 10,
        "contribution": 2
      },
      {
        "raw": 6.6,
        "label": "風險管理",
        "weight": "10/110",
        "normalized": 66,
        "contribution": 6.6
      },
      {
        "raw": 11.7,
        "label": "技術信號",
        "weight": "30/110",
        "normalized": 39,
        "contribution": 11.7
      },
      {
        "raw": 6,
        "label": "情緒分析",
        "weight": "10/110",
        "normalized": 60,
        "contribution": 6
      }
    ],
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "momentumMax": 50,
  "scoreStatus": "incomplete",
  "standard110": {
    "rating": "避免",
    "result": 42.6,
    "details": [
      "基本面分析總分: 4.5/5分",
      "資金流分析總分: 5.2/20分",
      "市場環境分析總分: 6.6/15分",
      "催化劑分析: 2/20分",
      "風險管理總分: 6.6/10分",
      "技術信號分析總分: 11.7/30分",
      "情緒分析: 6/10分",
      "共振率(僅顯示不加分): 0%"
    ],
    "formula": "基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10",
    "dimensionScores": {
      "催化劑": 2,
      "基本面": 4.5,
      "資金流": 5.2,
      "市場環境": 6.6,
      "情緒分析": 6,
      "技術信號": 11.7,
      "風險管理": 6.6
    },
    "dimensionDetails": {
      "催化劑": {
        "max": 20,
        "grade": "較差",
        "items": {
          "catalyst": {
            "score": 2,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 6,
              "catalystCount": 0
            }
          },
          "catalystPoints": 2
        }
      },
      "基本面": {
        "max": 5,
        "grade": "優秀",
        "items": {
          "pbPoints": 0.2,
          "pePoints": 0.2,
          "epsPoints": 0.75,
          "roePoints": 0.75,
          "debtPoints": 0.4,
          "marginPoints": 0.75,
          "turnoverUsdM": 202.69913211623,
          "volumePoints": 0.5,
          "revenuePoints": 0.4,
          "dividendPoints": 0,
          "marketCapPoints": 0.5
        },
        "source": "fmp_stable"
      },
      "資金流": {
        "max": 20,
        "grade": "較差",
        "items": {
          "cmfPoints": 0.8,
          "mfiPoints": 0.8,
          "obvPoints": 0.8,
          "vwapPoints": 0.8,
          "institutional": {
            "score": 2,
            "details": {
              "source": "optional-neutral",
              "warning": {
                "code": "INSTITUTIONAL_DATA_OPTIONAL",
                "symbol": "US.IDXX",
                "message": "Institutional ownership is unavailable; neutral 2/4 money-flow treatment used."
              },
              "optional": true,
              "holderCount": null,
              "holderPoints": 2,
              "top10ShareRatio": null,
              "concentrationPenalty": 0
            }
          },
          "institutionPoints": 2
        }
      },
      "市場環境": {
        "max": 15,
        "grade": "較差",
        "items": {
          "vix": {
            "score": 0,
            "details": {
              "source": "twelvedata+fred",
              "missing": true,
              "vixClose": null
            }
          },
          "trend": {
            "score": 2.8,
            "details": {
              "qqq": {
                "ma20": 715.6679992,
                "ma50": 710.4063990999997,
                "name": "QQQ",
                "close": 714.88,
                "points": 1.4
              },
              "spy": {
                "ma20": 766.87899445,
                "ma50": 758.61640102,
                "name": "SPY",
                "close": 764.28998,
                "points": 1.4
              },
              "source": "twelvedata+fred"
            }
          },
          "atrPct": 2.6800276861496397,
          "atrPoints": 3,
          "cciPoints": 0.8,
          "vixPoints": 0,
          "marketTrendPoints": 2.8
        }
      },
      "情緒分析": {
        "max": 10,
        "grade": "一般",
        "items": {
          "sentiment": {
            "score": 6,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 6,
              "negativeHits": 0,
              "positiveHits": 4,
              "sentimentScoreRaw": 1.6
            }
          },
          "sentimentData": {
            "raw": [
              {
                "id": 141282167,
                "url": "https://finnhub.io/api/news?id=fe0607e188cbb276b07af38333b8ff14d4e7ac54cea8ccd478fca5c0e294b6f5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IDXX",
                "summary": "Baron Capital, an investment management company, released its Q2 2026 investor letter for the “Baron Focused Growth Fund”. A copy of the letter can be downloaded here. In the second quarter, the Baron Focused Growth Fund achieved a 13.26% gain, still trailing the Russell 2500 Growth Index’s 24.02% return. The underperformance was driven by ongoing concerns […]",
                "category": "company",
                "datetime": 1787244148,
                "headline": "Rationale Behind Baron Focused Growth Fund’s IDEXX Laboratories (IDXX) Holding"
              },
              {
                "id": 141266861,
                "url": "https://finnhub.io/api/news?id=9cedcdf4c43cd7438e7b70ae9a03e3c4bf570d0f0bd5b655596aaaef72271d12",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IDXX",
                "summary": "IDEXX raises its 2026 EPS outlook as recurring diagnostics growth, wider margins and international expansion offset softer U.S. veterinary traffic.",
                "category": "company",
                "datetime": 1787243820,
                "headline": "IDXX Raises 2026 EPS Outlook as Diagnostic Growth and Margins Improve"
              },
              {
                "id": 141282177,
                "url": "https://finnhub.io/api/news?id=a860f44797bb4049afb87026628b9e4e61e6e69b9c0bda9d5d99d27a9e72bca4",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IDXX",
                "summary": "IDEXX pairs resilient diagnostics growth, margin gains and expanding innovation with a premium valuation that supports a hold-or-wait stance.",
                "category": "company",
                "datetime": 1787152080,
                "headline": "Is IDXX Worth Buying as Growth Strength Meets a Premium Valuation?"
              },
              {
                "id": 141249054,
                "url": "https://finnhub.io/api/news?id=f749751cdb9f8fb7137827041d977df8470ddebdf2739a50d63a1eb20d9a9b1b",
                "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
                "source": "SeekingAlpha",
                "related": "IDXX",
                "summary": "IDEXX Laboratories, Inc. (IDXX) Analyst/Investor Day August 13, 2026 8:00 AM EDTCompany ParticipantsMichael Erickson - CEO, President & DirectorJulie...",
                "category": "company",
                "datetime": 1787074911,
                "headline": "IDEXX Laboratories, Inc. (IDXX) Analyst/Investor Day Transcript"
              },
              {
                "id": 141217800,
                "url": "https://finnhub.io/api/news?id=9733f959f90841768c9c222e9aa0805ec2c918a9a94020d95ded6a90689077b8",
                "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
                "source": "SeekingAlpha",
                "related": "IDXX",
                "summary": "2026-08-14. The following slide deck was published by IDEXX Laboratories, Inc.",
                "category": "company",
                "datetime": 1786714465,
                "headline": "IDEXX Laboratories, Inc. (IDXX) Analyst/Investor Day - Slideshow"
              },
              {
                "id": 141202145,
                "url": "https://finnhub.io/api/news?id=76b885e3fe66a660c052540e4f5a9d561efa3455083cb1e765bd2c041e1371ec",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IDXX",
                "summary": "IDEXX Laboratories recently reported past second-quarter 2026 results showing higher revenue and earnings, and slightly raised its full-year 2026 guidance for revenue, operating margin and EPS. The company also introduced the Catalyst proBNP Test, the first dual-species, in-clinic NT-proBNP cardiac test, expanding its connected veterinary diagnostics portfolio and tapping into an underassessed companion-animal heart disease market. We’ll now examine how the new Catalyst proBNP Test and...",
                "category": "company",
                "datetime": 1786587011,
                "headline": "Will Strong Q2 2026 Results and New Cardiac Test Change IDEXX Laboratories' (IDXX) Narrative?"
              }
            ],
            "raw_source": [
              {
                "id": 142063291,
                "url": "https://finnhub.io/api/news?id=45a4c767641875677341490c5c57df95988778e7db0af9183d8a84bc58b8398b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IDXX",
                "summary": "If you hold Pfizer (PFE) or Zoetis (ZTS), you hold the same idea: a branded medicine becomes a standard of care and keeps earning for years, in people or in animals. That is where it stops. Pfizer is buying replacements for older drugs losing exclusivity. Zoetis is cutting its effective price to keep the franchises it has. Same bet, two opposite defenses.",
                "category": "company",
                "datetime": 1789059954,
                "headline": "Pfizer Stock Or Zoetis: Is The Comeback Worth Paying Up For?"
              },
              {
                "id": 142060161,
                "url": "https://finnhub.io/api/news?id=57e39d64a6d8b3ccef6bec1c6dd61092ebd9edef3f36bd0690b13626d83d3d1b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IDXX",
                "summary": "Kingsley exercised options at $114.17 per share before immediately selling at $532.08, capturing a significant gain. His direct stake remains at 9,568 shares worth $5.12 million.",
                "category": "company",
                "datetime": 1789039201,
                "headline": "Insider Alert: IDEXX Director Lawrence Kingsley Sells $1.2 Million of Stock"
              },
              {
                "id": 142086761,
                "url": "https://finnhub.io/api/news?id=c09628bcf5f21f4776a3b3675749871ba5c376e376db4a730357955e1ab55212",
                "image": "https://cdn.benzinga.com/files/images/story/2025/11/06/insider_trade_3.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "IDXX",
                "summary": "In a new SEC filing on September 9, it was revealed that Kingsley, Board Member at IDEXX Laboratories (NASDAQ:IDXX), executed a significant exercise of company stock options.\nWhat Happened: Disclosed in a Form 4 filing",
                "category": "company",
                "datetime": 1789038085,
                "headline": "Engaging In Options Activity, Lawrence D Kingsley Exercises Options Valued At $873K In IDEXX Laboratories"
              },
              {
                "id": 142061148,
                "url": "https://finnhub.io/api/news?id=7f0de51f256b61b9df0e35d286863ba8fe033eb1dbec973436a99a804309379f",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1351963587/image_1351963587.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "IDXX",
                "summary": "Top contributors include Space Exploration Technologies, Tesla, Red Rock Resorts, Hyatt Hotels and Birkenstock Holding. Read more here.",
                "category": "company",
                "datetime": 1789035300,
                "headline": "Baron Partners Fund Q2 2026 Contributors And Detractors"
              },
              {
                "id": 142062118,
                "url": "https://finnhub.io/api/news?id=1d4950ac362cdb63b062bee890fd5d2a425808e745bafddbf3ac1c4a50640db9",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IDXX",
                "summary": "Despite trailing the Dow over the past year, IDEXX still has Wall Street on its side, with analysts maintaining a cautiously optimistic view on its future prospects.",
                "category": "company",
                "datetime": 1789032067,
                "headline": "Is IDEXX Laboratories Stock Underperforming the Dow?"
              },
              {
                "id": 141399397,
                "url": "https://finnhub.io/api/news?id=e9276ab12e47a0d3dd90df920e651f06fcf504acce7c2175389d383dc3c70589",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1972334358/image_1972334358.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "IDXX",
                "summary": "The Fund's weightings are significantly different than those of the Benchmark, which explains why the Fund has such high active share of almost 100%. Read more here.",
                "category": "company",
                "datetime": 1788429000,
                "headline": "Baron Focused Growth Fund Q2 2026 Portfolio Update"
              },
              {
                "id": 141361360,
                "url": "https://finnhub.io/api/news?id=b3dce0b1c9a4c4655954dc9ce268a2fa6b35340cb08c89f935eac9e3aa25c5c7",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IDXX",
                "summary": "WESTBROOK, Maine, August 31, 2026--IDEXX Laboratories, Inc. (Nasdaq: IDXX), a global leader in pet healthcare innovation, today announced that Mike Erickson, President and Chief Executive Officer, and Andrew Emerson, Executive Vice President and Chief Financial Officer, will participate in a fireside chat at the Morgan Stanley 24th Annual Global Healthcare Conference on Monday, September 14, 2026, from 10:45 am – 11:20 am (ET).",
                "category": "company",
                "datetime": 1788202800,
                "headline": "IDEXX Laboratories to Participate in Morgan Stanley 24th Annual Global Healthcare Conference"
              },
              {
                "id": 141350993,
                "url": "https://finnhub.io/api/news?id=891189d904c37cd1a42d9adf35703a2729dacbb6529f24d5bb557f9ddb970015",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/538053368/image_538053368.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "IDXX",
                "summary": "Fundsmith's 13F portfolio rose to ~$13.65B in Q2 2026, expanding holdings from 34 to 41. Click here to read more about the portfolio.",
                "category": "company",
                "datetime": 1788120600,
                "headline": "Tracking Terry Smith's Fundsmith 13F Portfolio - Q2 2026 Update"
              },
              {
                "id": 141364090,
                "url": "https://finnhub.io/api/news?id=7c0585d260597d99380d2de76bf5fb3aabaa1011a7e5906d1f1329d4b85aae48",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IDXX",
                "summary": "IDEXX Laboratories has struggled to keep pace with the broader market over the past year, but Wall Street still sees plenty of room for the stock to recover, with analysts maintaining a moderately bullish outlook on its prospects.",
                "category": "company",
                "datetime": 1787749740,
                "headline": "Are Wall Street Analysts Predicting IDEXX Laboratories Stock Will Climb or Sink?"
              },
              {
                "id": 141318391,
                "url": "https://finnhub.io/api/news?id=04db770f3b1bf7580634a4c65cd6f3be07a98eab6b7e4a08efd64aa40c9465d1",
                "image": "https://cdn.benzinga.com/files/images/story/2025/11/06/insider_trade_3.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "IDXX",
                "summary": "In a new SEC filing on August 24, it was revealed that Emerson, EVP at IDEXX Laboratories (NASDAQ:IDXX), executed a significant exercise of company stock options.\nWhat Happened: A Form 4 filing with the U.S. Securities",
                "category": "company",
                "datetime": 1787655697,
                "headline": "Insider Decision: Andrew Emerson Exercises Options At IDEXX Laboratories For $101K"
              },
              {
                "id": 141282166,
                "url": "https://finnhub.io/api/news?id=9844c02bdd1c3c2ee15b98419ad72a25530cf1cd691f26279cf2288e964f3c64",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IDXX",
                "summary": "IDXX's CAG diagnostics and cloud software growth support recurring revenues, while FX exposure and distributor inventory swings remain key risks.",
                "category": "company",
                "datetime": 1787324040,
                "headline": "Is it a Prudent Move to Retain IDEXX Stock in Your Portfolio Now?"
              },
              {
                "id": 141282167,
                "url": "https://finnhub.io/api/news?id=fe0607e188cbb276b07af38333b8ff14d4e7ac54cea8ccd478fca5c0e294b6f5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IDXX",
                "summary": "Baron Capital, an investment management company, released its Q2 2026 investor letter for the “Baron Focused Growth Fund”. A copy of the letter can be downloaded here. In the second quarter, the Baron Focused Growth Fund achieved a 13.26% gain, still trailing the Russell 2500 Growth Index’s 24.02% return. The underperformance was driven by ongoing concerns […]",
                "category": "company",
                "datetime": 1787244148,
                "headline": "Rationale Behind Baron Focused Growth Fund’s IDEXX Laboratories (IDXX) Holding"
              },
              {
                "id": 141266861,
                "url": "https://finnhub.io/api/news?id=9cedcdf4c43cd7438e7b70ae9a03e3c4bf570d0f0bd5b655596aaaef72271d12",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IDXX",
                "summary": "IDEXX raises its 2026 EPS outlook as recurring diagnostics growth, wider margins and international expansion offset softer U.S. veterinary traffic.",
                "category": "company",
                "datetime": 1787243820,
                "headline": "IDXX Raises 2026 EPS Outlook as Diagnostic Growth and Margins Improve"
              },
              {
                "id": 141282177,
                "url": "https://finnhub.io/api/news?id=a860f44797bb4049afb87026628b9e4e61e6e69b9c0bda9d5d99d27a9e72bca4",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IDXX",
                "summary": "IDEXX pairs resilient diagnostics growth, margin gains and expanding innovation with a premium valuation that supports a hold-or-wait stance.",
                "category": "company",
                "datetime": 1787152080,
                "headline": "Is IDXX Worth Buying as Growth Strength Meets a Premium Valuation?"
              },
              {
                "id": 141249054,
                "url": "https://finnhub.io/api/news?id=f749751cdb9f8fb7137827041d977df8470ddebdf2739a50d63a1eb20d9a9b1b",
                "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
                "source": "SeekingAlpha",
                "related": "IDXX",
                "summary": "IDEXX Laboratories, Inc. (IDXX) Analyst/Investor Day August 13, 2026 8:00 AM EDTCompany ParticipantsMichael Erickson - CEO, President & DirectorJulie...",
                "category": "company",
                "datetime": 1787074911,
                "headline": "IDEXX Laboratories, Inc. (IDXX) Analyst/Investor Day Transcript"
              },
              {
                "id": 141244827,
                "url": "https://finnhub.io/api/news?id=4bbe06faed3e1b5edb92c18be41d38eeb7755145d4ccb98ff584a7466cca18b0",
                "image": "",
                "source": "SeekingAlpha",
                "related": "IDXX",
                "summary": "",
                "category": "company",
                "datetime": 1787030652,
                "headline": "IDEXX Labs Executing, But Valuation Continues To Weigh On That Execution"
              },
              {
                "id": 141244707,
                "url": "https://finnhub.io/api/news?id=3bac2186ba9b1a233c3f09f7d3dfe51c5bccec143ea224e6f321db1cfa907c7a",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2221619913/image_2221619913.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "IDXX",
                "summary": "Despite aggressive competitor promotions, Zoetis protects industry-leading profitability. Click here to find out why ZTS stock is a Buy.",
                "category": "company",
                "datetime": 1787027922,
                "headline": "Zoetis: A Solid Long-Term Buy After Harsh Drawdown"
              },
              {
                "id": 141282178,
                "url": "https://finnhub.io/api/news?id=7a7a8cb854b7c466817cbb00f552a272699c43555da411c2b5055911cafd6651",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IDXX",
                "summary": "IDEXX Laboratories (NASDAQ:IDXX) outlined an innovation-led growth strategy at its 2026 Investor Day, highlighting a $45 billion global companion-animal testing opportunity, expanded commercial investments and a pipeline of diagnostic, software and artificial-intelligence offerings intended to incre",
                "category": "company",
                "datetime": 1786734186,
                "headline": "IDEXX Laboratories Targets $45B Pet Diagnostics Opportunity With AI, Cancer Tests"
              },
              {
                "id": 141217800,
                "url": "https://finnhub.io/api/news?id=9733f959f90841768c9c222e9aa0805ec2c918a9a94020d95ded6a90689077b8",
                "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
                "source": "SeekingAlpha",
                "related": "IDXX",
                "summary": "2026-08-14. The following slide deck was published by IDEXX Laboratories, Inc.",
                "category": "company",
                "datetime": 1786714465,
                "headline": "IDEXX Laboratories, Inc. (IDXX) Analyst/Investor Day - Slideshow"
              },
              {
                "id": 141202145,
                "url": "https://finnhub.io/api/news?id=76b885e3fe66a660c052540e4f5a9d561efa3455083cb1e765bd2c041e1371ec",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IDXX",
                "summary": "IDEXX Laboratories recently reported past second-quarter 2026 results showing higher revenue and earnings, and slightly raised its full-year 2026 guidance for revenue, operating margin and EPS. The company also introduced the Catalyst proBNP Test, the first dual-species, in-clinic NT-proBNP cardiac test, expanding its connected veterinary diagnostics portfolio and tapping into an underassessed companion-animal heart disease market. We’ll now examine how the new Catalyst proBNP Test and...",
                "category": "company",
                "datetime": 1786587011,
                "headline": "Will Strong Q2 2026 Results and New Cardiac Test Change IDEXX Laboratories' (IDXX) Narrative?"
              }
            ],
            "data_source": "finnhub_news_keyword_model",
            "article_count": 6,
            "negative_hits": 0,
            "positive_hits": 4,
            "recomputed_at_score": true,
            "sentiment_score_raw": 1.6,
            "source_article_count": 20,
            "discarded_article_count": 14
          },
          "sentimentPoints": 6
        }
      },
      "技術信號": {
        "max": 30,
        "raw": 11.7,
        "grade": "較差",
        "items": {
          "bbPoints": 1.8,
          "adxPoints": 3,
          "sarPoints": 1.2000000000000002,
          "vcpPoints": 1.8,
          "macdPoints": 0.8,
          "vcpPayload": {
            "vcp_pass": false,
            "vcp_score": 1.8,
            "vcp_reason": "波幅收縮(23.7%→11.2%)；跌縮量(近10日4日)；Ready=N；Confirm=N",
            "vcp_metrics": {
              "up_days": 3,
              "vol_ref": 590596.6666666666,
              "down_days": 6,
              "vcp_ready": false,
              "above_ma50": false,
              "avg_vol_10": 508340,
              "avg_vol_20": 505445,
              "avg_vol_30": 590596.6666666666,
              "range_pct_10": 0.11188824822888357,
              "range_pct_20": 0.14329311584519278,
              "range_pct_30": 0.2365366111246957,
              "up_expand_ok": false,
              "lookback_used": 59,
              "near_20d_high": false,
              "contraction_ok": true,
              "down_shrink_ok": true,
              "up_expand_days": 1,
              "breakout_20d_ok": false,
              "vol_ratio_10_30": 0.8607227718860588,
              "dist_to_20d_high": 0.12543972970096043,
              "down_shrink_days": 4,
              "breakout_level_20d": 577.090027,
              "vcp_breakout_confirm": false,
              "contraction_ratio_10_30": 0.4730271888857794
            },
            "vcp_name_en": "Volatility Contraction Pattern",
            "vcp_name_zh": "波動收縮形態",
            "vol_contraction": true
          },
          "kdjAdxPoints": 0.5,
          "rsiKdjPoints": 0.8,
          "volumeWeight": 2,
          "maCrossPoints": 0,
          "shortRsiPoints": 0,
          "shortMacdPoints": 0.4,
          "volConfirmPoints": 0.6,
          "volumePointsTechnical": 0.8
        }
      },
      "風險管理": {
        "max": 10,
        "grade": "一般",
        "items": {
          "position": {
            "score": 1.4,
            "details": {
              "atrPct": 2.6800276861496397,
              "turnoverUsdM": 202.69913211623,
              "liquidityPoints": 0.4,
              "volatilityPoints": 1
            }
          },
          "rrPoints": 1.4,
          "stopLevels": {
            "symbol": "US.IDXX",
            "rr_range": "1:1.0-1:2.5",
            "risk_profile": "中等",
            "stop_loss_price": 477.6478,
            "strength_details": {
              "ma_score": 1,
              "atr_score": 2,
              "rsi_score": 2.5,
              "macd_score": 1,
              "volume_score": 1
            },
            "market_adjustment": 1,
            "risk_reward_ratio": 1,
            "stop_loss_percent": 5.4,
            "take_profit_price": 529.935,
            "target_multiplier": 1.6,
            "technical_strength": 1.45,
            "take_profit_percent": 5
          },
          "positionPoints": 1.4,
          "stopLossPoints": 1.8,
          "diversification": {
            "score": 2,
            "details": {
              "method": "sector concentration proxy; no portfolio holdings used",
              "sector": "Health Care",
              "concentratedSectorPenalty": 0
            }
          },
          "riskRewardRatio": 1.2,
          "stopLossPercent": 5.360055372299279,
          "diversificationPoints": 2
        }
      }
    }
  },
  "modelVersion": "cursor_18_27_news_v2_160",
  "providerErrors": [
    {
      "code": "VIX_MISSING",
      "symbol": "US.IDXX",
      "message": "VIX market context is required for market environment scoring",
      "missing": [
        "VIX"
      ],
      "provider": "scoring"
    }
  ],
  "rankingScoreMax": 160,
  "dataCompleteness": {
    "complete": false,
    "missingFields": [
      "VIX"
    ],
    "optionalInputs": [
      "institutionalData"
    ],
    "requiredInputs": [
      "fundamentals",
      "marketContext.VIX",
      "marketContext.SPY",
      "marketContext.QQQ",
      "catalystData",
      "sentimentData",
      "ATR",
      "sector"
    ],
    "optionalInputWarnings": []
  },
  "technicalIndicators": {
    "adx": 100,
    "atr": {
      "atr": 13.5261,
      "rule": "ATR / current price; lower volatility scores higher",
      "score": 6,
      "atr_pct": 2.68
    },
    "cci": {
      "rule": "Cursor_18.24 CCI bands",
      "level": "超買或超賣風險",
      "score": 2,
      "value": -182.01
    },
    "cmf": {
      "rule": "Cursor_18.24 CMF bands",
      "level": "派發",
      "score": 2,
      "value": -0.2295
    },
    "kdj": {
      "d": 13.25,
      "j": -0.21,
      "k": 8.76,
      "rule": "Cursor_18.24 K/D cross",
      "score": 0,
      "signal": "死叉"
    },
    "mfi": {
      "rule": "Cursor_18.24 MFI bands",
      "level": "超賣或超買風險",
      "score": 2,
      "value": 22.32
    },
    "obv": {
      "rule": "Cursor_18.24 recent_slope vs previous_slope",
      "score": 2,
      "trend": "資金流出",
      "value": 1473477,
      "recentSlope": -259112.3,
      "previousSlope": 51270
    },
    "rsi": 23.79,
    "sar": {
      "rule": "Cursor_18.24 Parabolic SAR",
      "score": 4,
      "trend": "下降",
      "value": 566.1263,
      "position": "SAR喺價上",
      "distancePct": 12.17,
      "previousTrend": "下降"
    },
    "ma50": 556.0482,
    "macd": {
      "macd": -13.110220592590053,
      "trend": "看跌",
      "signal": -8.21675543510298,
      "histogram": -4.893465157487073
    },
    "vwap": {
      "rule": "Cursor_18.24 VWAP 20D consecutive close",
      "score": 2,
      "value": 542.732,
      "position": "<VWAP",
      "consecutiveAbove": 0
    },
    "volume": {
      "rule": "Cursor_18.24 volume ratio",
      "level": "無力",
      "ratio": 0.8,
      "score": 4,
      "avgVolume": 499946,
      "currentVolume": 401623
    },
    "derived": {
      "ma20": 541.5245,
      "ma50": 556.0482,
      "prevClose": 506.53,
      "avgVolume10": 514452,
      "avgVolume20": 499946,
      "changePercent": -0.36,
      "avgVolumeForScore": 499946
    },
    "ma_cross": {
      "ma20": 541.5245,
      "ma50": 556.0482,
      "rule": "Cursor_18.24 MA20/MA50 cross",
      "cross": "熊勢",
      "score": 0,
      "prevMa20": 544.636,
      "prevMa50": 556.7058,
      "spreadPct": 2.61,
      "isVolumeBreakout": false
    },
    "bollinger": {
      "lower": 507.3728,
      "upper": 575.6762,
      "position": "下半部"
    },
    "rsi_short": 13.11,
    "macd_short": {
      "macd": 0,
      "trend": "中性",
      "signal": 0,
      "histogram": 0
    },
    "volume_ratio": {
      "ratio": 0.8
    }
  }
}

{
  "close": 504.7,
  "volume": 401623,
  "changePercent": -0.36
}